Tags |
|
|
Links |
|
|
Advice You - Negotiation-Dealing With Price And The Closing Stages
Overcoming the Price Objection:
Price is an issue in most negotiations. We need to deal with the price issue confidently, but with an understanding of t
Price is an issue in most negotiations. We need to deal with the price issue confidently, but with an understanding of t
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
he needs of the other side. Here are some notes to help you:
• Be specific. State the exact price rather than ....well, it will be about ?5,000.
• Maintain ey
• Be specific. State the exact price rather than ....well, it will be about ?5,000.
• Maintain ey
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
e contact. It makes you look confident.
• Ensure the tone of your voice is confident and your body language is also confident and relaxed.
• Use silence. Once
• Ensure the tone of your voice is confident and your body language is also confident and relaxed.
• Use silence. Once
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
you have stated your price, stop talking and wait for the other side to speak. Give them time to think.
• Deal with price objections and defend your price, bu
• Deal with price objections and defend your price, bu
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
don’t over argue your case.
• Close down your body language.
• Focus on price and benefit differences.
• Begin the bargaining phase.
The Closing Stages<
• Close down your body language.
• Focus on price and benefit differences.
• Begin the bargaining phase.
The Closing Stages<
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
/b>:
The closing stages of any negotiation are vital to the overall success of the final deal. There will come a time when both parties can sense an outcome is
The closing stages of any negotiation are vital to the overall success of the final deal. There will come a time when both parties can sense an outcome is
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
possible, and each negotiator needs to be careful not to be too eager to close or else the other party will be tempted to hold back for further concessions.
O
O
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ce a likely outcome is seen, either party may define outstanding issues, compare arguments and objections, review the position to date and agree a deadline for
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
agreement. If one side avoids making these decisions, the other must probe to find out the reason and deal with it effectively. Negotiators must be careful at t
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
his stage to identify tactical delay which deliberately attempts to force further concessions.
The best solution to aim for always, is one where both parties f
The best solution to aim for always, is one where both parties f
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
el they have done well despite having to concede on certain issues. This is called a “win-win” solution. Once either side feels they have arrived at the final d
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
eal, it is important to signal this to the other party.
Body language can say as much about what you are thinking as speech. If you have made your final offer,
Body language can say as much about what you are thinking as speech. If you have made your final offer,
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
look as if it is your final offer. Simply gathering up your papers, looking at the other side directly in the eye and saying “That is my final offer”, can do t
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
his, and silence can be a powerful tool in convincing them you mean what you say.
Be wary of "splitting the difference": If you offer to split the difference,
Be wary of "splitting the difference": If you offer to split the difference,
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ou have, in effect, given the other side a concession that is one-sided. You have said you are prepared to move without asking for commitment in return.
The fi
The fi
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
nal consideration is when you have done the deal and both parties are in agreement. Record the details and agree with the other parties involved that your inter
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
pretation of events matches theirs. That way there will be no unexpected comeback in the inevitable post-negotiation period when either side reviews how well or
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
badly he has done. Again, this will be minimised if the solution you have
arrived at benefits both parties.
A Final Word Of Caution:
The closing stag
A Final Word Of Caution:
The closing stag
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
es need to be approached with caution. It has been shown that the majority of concessions are given or traded in the last 5% of the time allocated for negotiati
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
on. That means if you negotiate for one hour, the last three minutes are when you are most vulnerable.
Copyright © 2007 Jonathan Farrington. All rights reserve
Copyright © 2007 Jonathan Farrington. All rights reserve
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/31153/adviceyou-NegotiationDealing-With-Price-And-The-Closing-Stages.html">Negotiation-Dealing With Price And The Closing Stages</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/31153/adviceyou-NegotiationDealing-With-Price-And-The-Closing-Stages.html]Negotiation-Dealing With Price And The Closing Stages[/url]
Related Articles:
'Gold' Standard Customer Service is Still Key to Growing Your Business
Article Marketing - What's The Difference?
Bookmark it:
|